vimarsana.com

Latest Breaking News On - Sanjk patel - Page 1 : vimarsana.com

Wells Fargo & Company Begins Coverage on Kiniksa Pharmaceuticals (NASDAQ:KNSA)

Wells Fargo & Company Begins Coverage on Kiniksa Pharmaceuticals (NASDAQ:KNSA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Sanjk-patel
Kiniksa-pharmaceuticals
Altitude-crest-partners-inc
Jpmorgan-chase-co
Kiniksa-pharmaceuticals-ltd
Peregrine-capital-management
Parkman-healthcare-partners
Kiniksa-pharmaceuticals-stock-down
Connor-clark-lunn-investment-management-ltd
Wells-fargo-company
Granahan-investment-management

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $30.00 at JPMorgan Chase & Co.

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $30.00 at JPMorgan Chase & Co.
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Michaelr-megna
Sanjk-patel
Victory-capital-management-inc
Sg-americas-securities
Hedge-funds-weigh-in-on-kiniksa-pharmaceuticals
News-ratings-for-kiniksa-pharmaceuticals-daily
Kiniksa-pharmaceuticals-company-profile
Insider-activity-at-kiniksa-pharmaceuticals
Capital-management-inc
Jpmorgan-chase-co

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Forecasted to Post Q2 2024 Earnings of ($0.06) Per Share

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Forecasted to Post Q2 2024 Earnings of ($0.06) Per Share
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Sanjk-patel
Michaelr-megna
Nasdaq
News-ratings-for-kiniksa-pharmaceuticals-daily
Kiniksa-pharmaceuticals-company-profile
Kiniksa-pharmaceuticals-ltd
Granahan-investment-management
Institutional-trading-of-kiniksa-pharmaceuticals
Parkman-healthcare-partners
Opaleye-management-inc
Allspring-global-investments-holdings

Evercore ISI Increases Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00

Evercore ISI Increases Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Michaelr-megna
Sanjk-patel
Principal-financial-group-inc
Insider-transactions-at-kiniksa-pharmaceuticals
Securities-exchange-commission
Linden-thomas-advisory-services
China-universal-asset-management-co
Connor-clark-lunn-investment-management-ltd
Kiniksa-pharmaceuticals-stock-performance
Kiniksa-pharmaceuticals-ltd

Linden Thomas Advisory Services LLC Has $2.01 Million Holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)

Linden Thomas Advisory Services LLC cut its position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 1.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 114,550 shares of the company’s stock after selling 1,341 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in Kiniksa Pharmaceuticals were worth $2,009,000 as of […]

Sanjk-patel
News-ratings-for-kiniksa-pharmaceuticals-daily
Acadian-asset-management
Connor-clark-lunn-investment-management-ltd
Nasdaq
Schonfeld-strategic-advisors
Quarter-for-kiniksa-pharmaceuticals
Kiniksa-pharmaceuticals-company-profile
Kiniksa-pharmaceuticals-stock
Linden-thomas-advisory-services
Securities-exchange-commission

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.